These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6775184)

  • 61. [Recent research on derivatives of 8-oxyquinoline. New 7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines and 5-chloro-7-arylglyoxylidenehydrazinomethyl-8-oxyquinolines].
    Tajana A; Nardi D; Veronese M
    Boll Chim Farm; 1975 Aug; 114(8):440-4. PubMed ID: 810149
    [No Abstract]   [Full Text] [Related]  

  • 62. New orally effective iron chelators. Animal studies.
    Hershko C; Link G; Pinson A; Avramovici-Grisaru S; Sarel S; Peter HH; Hider RC; Grady RW
    Ann N Y Acad Sci; 1990; 612():351-60. PubMed ID: 2291563
    [No Abstract]   [Full Text] [Related]  

  • 63. Combined cycloheximide and 8-hydroxyquinoline pretreatment for study of plant chromosomes.
    Tlaskal J
    Stain Technol; 1979 Nov; 54(6):313-9. PubMed ID: 121174
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The hyperglycemic activity of 2, 2'-bipyridine.
    KENNY AD; MOREY ER
    J Pharmacol Exp Ther; 1962 Mar; 135():317-22. PubMed ID: 14455211
    [No Abstract]   [Full Text] [Related]  

  • 65. The cause of blindness in dogs given hydroxypyridinethione.
    DELAHUNT CS; STEBBINS RB; ANDERSON J; BAILEY J
    Toxicol Appl Pharmacol; 1962 May; 4():286-91. PubMed ID: 13885037
    [No Abstract]   [Full Text] [Related]  

  • 66. Synthesis and study of pyridylalanine n-oxides.
    Sullivan PT; Kester M; Norton SJ
    J Med Chem; 1968 Nov; 11(6):1172-6. PubMed ID: 4878440
    [No Abstract]   [Full Text] [Related]  

  • 67. Enzymology: Tracking off-targets.
    Farrell A
    Nat Chem Biol; 2017 Jul; 13(8):817. PubMed ID: 28853735
    [No Abstract]   [Full Text] [Related]  

  • 68. BIA 10-2474: Some Lessons are Clear but Important Questions Remain Unanswered.
    Peck RW; Holstein SA; van der Graaf PH
    Clin Pharmacol Ther; 2022 Feb; 111(2):343-345. PubMed ID: 35007339
    [No Abstract]   [Full Text] [Related]  

  • 69. Reply to Letter: The Use of IC50 for Potency and MTD as Objective in Study BIA 10-2474, by Mattheus van Iersel, MD.
    Chaikin P
    J Clin Pharmacol; 2017 Oct; 57(10):1359-1361. PubMed ID: 28815653
    [No Abstract]   [Full Text] [Related]  

  • 70. About fundamentals and sermonizers. Author's response to the letter on the article "The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: Are we missing the fundamentals?".
    Funck-Brentano C; Ménard J
    Presse Med; 2017 Mar; 46(3):352-353. PubMed ID: 28237497
    [No Abstract]   [Full Text] [Related]  

  • 71. Antimalarial and antimicrobial activities of 8-Aminoquinoline-Uracils metal complexes.
    Phopin K; Sinthupoom N; Treeratanapiboon L; Kunwittaya S; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    EXCLI J; 2016; 15():144-52. PubMed ID: 27103894
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The utility of iron chelators in the management of inflammatory disorders.
    Lehmann C; Islam S; Jarosch S; Zhou J; Hoskin D; Greenshields A; Al-Banna N; Sharawy N; Sczcesniak A; Kelly M; Wafa K; Cheliak W; Holbein B
    Mediators Inflamm; 2015; 2015():516740. PubMed ID: 25878400
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications.
    Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Drug Des Devel Ther; 2013; 7():1157-78. PubMed ID: 24115839
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Superinfection in malaria: Plasmodium shows its iron will.
    Portugal S; Drakesmith H; Mota MM
    EMBO Rep; 2011 Dec; 12(12):1233-42. PubMed ID: 22081142
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro activities of novel catecholate siderophores against Plasmodium falciparum.
    Pradines B; Ramiandrasoa F; Basco LK; Bricard L; Kunesch G; Le Bras J
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2094-8. PubMed ID: 8878587
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
    Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
    Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro.
    Nickell SP; Scheibel LW; Cole GA
    Infect Immun; 1982 Sep; 37(3):1093-100. PubMed ID: 6752020
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Polyamine oxidase-mediated intraerythrocytic killing of Plasmodium falciparum: evidence against the role of reactive oxygen metabolites.
    Rzepczyk CM; Saul AJ; Ferrante A
    Infect Immun; 1984 Jan; 43(1):238-44. PubMed ID: 6360897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deferoxamine inhibition of malaria is independent of host iron status.
    Hershko C; Peto TE
    J Exp Med; 1988 Jul; 168(1):375-87. PubMed ID: 3294334
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimalarial activity of selected aromatic chelators.
    Scheibel LW; Adler A
    Mol Pharmacol; 1980 Sep; 18(2):320-5. PubMed ID: 6775184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.